Head-To-Head Comparison: Syra Health (NASDAQ:SYRA) & McKesson Europe (OTCMKTS:CAKFY)

Institutional and Insider Ownership

0.0% of McKesson Europe shares are owned by institutional investors. Comparatively, 4.8% of Syra Health shares are owned by institutional investors. 36.5% of Syra Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares McKesson Europe and Syra Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
McKesson Europe	N/A	N/A	N/A
Syra Health	-54.90%	-131.94%	-99.19%

Valuation and Earnings

This table compares McKesson Europe and Syra Health”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson Europe	N/A	N/A	N/A	$0.09	47.67
Syra Health	$7.98 million	1.56	-$2.94 million	$0.01	90.00

McKesson Europe has higher earnings, but lower revenue than Syra Health. McKesson Europe is trading at a lower price-to-earnings ratio than Syra Health, indicating that it is currently the more affordable of the two stocks.

Summary

McKesson Europe beats Syra Health on 5 of the 8 factors compared between the two stocks.

About McKesson Europe

McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products. This division serves its customers through 90 wholesale branches that supply pharmaceutical products to approximately 40,000 pharmacies and hospitals, as well as operates 70 distribution centers in Europe. The Retail Pharmacy division operates approximately 2,000 owned pharmacies and approximately 8,000 members in its brand partnership program. This division also provides outpatient drug, e-commerce, and home care services primarily in Belgium, Ireland, Italy, and the United Kingdom under the Lloyds Pharmacy brand. In addition, this division provides traditional prescription drugs, over-the-counter products, and medical services. It also provides other services for pharmacists, such as the organization and management of pharmacy cooperation programs in the Great Britain, France, Portugal, and Belgium. The company was formerly known as Celesio AG and changed its name to McKesson Europe AG in September 2017. The company was founded in 1835 and is headquartered in Stuttgart, Germany. McKesson Europe AG is a subsidiary of McKesson Corporation.

About Syra Health

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.